Author

Xavier Choderlos de Laclos

Observed names: X. Choderlos de Laclos, XAVIER CHODERLOS DE LACLOS, Xavier Choderlos De Laclos

Institution: Centre Eugène Marquis

Observed institution: Centre Eugène Marquis

OpenAlex ID: A5059028136

Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials

2024 · Xavier Choderlos de Laclos, Séverine Risbourg, et al. · European Journal of Cancer · 7

Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study

2022 · XAVIER CHODERLOS DE LACLOS, DIDIER FRAPPAZ, et al. · Anticancer Research · 5

470P Real-world safety and effectiveness of sacituzumab govitecan in older patients with HR+/HER2- and triple-negative advanced breast cancer: The S-GOLD study

2026 · B. Poirier, A.A. Viansone, et al. · ESMO Open

Incidence, caractéristiques et survie des patients présentant une pneumocystose en oncologie solide

2024 · Alexandre Peinoit, Léa Muzellec, et al. · Bulletin du Cancer

Works count: 4

Citation count: 11

H-index: 2

I10-index: